share_log

Recursion Pharmaceuticals | 8-K: Current report

SEC announcement ·  Jun 7 21:01
Summary by Futu AI
Recursion Pharmaceuticals, Inc. conducted its 2024 annual meeting of stockholders on June 3, 2024. During the meeting, two Class III directors were elected to serve until the 2027 annual meeting. The elected directors are Blake Borgeson, Ph.D., with 165,914,956 votes for and 26,093,759 withheld, and Dean Y. Li, M.D., Ph.D., with 166,211,058 votes for and 25,797,657 withheld. Additionally, an advisory resolution to approve executive compensation was passed with 188,317,831 votes for, 2,887,180 against, and 803,704 abstentions. The details of these proposals and their descriptions were previously filed with the SEC in the definitive Proxy Statement on April 23, 2024. The annual meeting's outcomes were reported in compliance with the SEC regulations.
Recursion Pharmaceuticals, Inc. conducted its 2024 annual meeting of stockholders on June 3, 2024. During the meeting, two Class III directors were elected to serve until the 2027 annual meeting. The elected directors are Blake Borgeson, Ph.D., with 165,914,956 votes for and 26,093,759 withheld, and Dean Y. Li, M.D., Ph.D., with 166,211,058 votes for and 25,797,657 withheld. Additionally, an advisory resolution to approve executive compensation was passed with 188,317,831 votes for, 2,887,180 against, and 803,704 abstentions. The details of these proposals and their descriptions were previously filed with the SEC in the definitive Proxy Statement on April 23, 2024. The annual meeting's outcomes were reported in compliance with the SEC regulations.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.